This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Secondary prophylaxis

Authoring team

Secondary prevention is required because subsequent streptococcal infection may precipitate recurrences of rheumatic fever.

Prophylaxis is effective as the bacterium does not become resistant to penicillin. Possible prophylactic measures include:

  • oral penicillin 125 mg b.d.
  • oral sulphonamide eg. sulphadimidine 0.5 g b.d.
  • monthly administration of benzathine penicillin G
  • for patients who are allergic to penicillin then erythromycin 250 mg b.d. can be used

Prophylaxis is given for at least 5 years. The duration of prophylaxis is dependent on whether there was carditis in the initial attack.

If there was no carditis in the initial attack then prophylaxis should be continued for 5 years - most recurrences occur within the first 5 years after the initial attack.

If a patient did suffer cardiac involvement with the initial attack then they should continue prophylaxis until the age of 25 years. Prophylaxis may be continued past this age if environmental conditions allow.

After 5 years or age 25 patients should have antibiotics for dental and other operative procedures for life.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.